Comparison of assessments based on the presence or absence of skin disease activity and damage
| Cutaneous activity | Cutaneous damage | |||||
|---|---|---|---|---|---|---|
| Yes (N=99) | No (N=10) | p-value | Yes (N=63) | No (N=46) | p-value | |
| SLEDAI-2K | 5.05 (±3.22) | 2.00 (±1.33) | <0.001 | 4.86 (±2.87) | 4.64 (±3.68) | 0.737 |
| CLASI activity | 7.73 (±6.90) | 0 (±0) | <0.001 | 8.49 (±8.10) | 4.96 (±4.17) | 0.004 |
| CLASI damage | 4.42 (±6.3) | 7.70 (±7.86) | 0.229 | 8.10 (±6.63) | 0 (±0) | <0.001 |
| LIT | 31.81 (±22.65) | 21.80 (±17.68) | 0.178 | 34.04 (±22.81) | 25.94 (±20.94) | 0.075 |
| SLAQ | 19.38 (±12.73) | 13.50 (±2.12) | 0.519 | 19.97 (±13.36) | 18.35 (±11.80) | 0.587 |
| FACIT-F | 33.80 (±12.24) | 34.50 (±13.22) | 0.865 | 32.20 (±12.59) | 36.33 (±11.50) | 0.100 |
| HADS anxiety | 6.79 (±3.76) | 5.11 (±2.67) | 0.195 | 6.46 (±4.27 | 6.87 (±2.68) | 0.569 |
| HADS depression | 7.24 (±4.42) | 7.00 (±1.94) | 0.773 | 7.73 (±4.55) | 6.49 (±3.70) | 0.149 |
| Skindex-16 symptoms | 48.18 (±34.73) | 12.93 (±15.64) | <0.001 | 45.92 (±35.64) | 43.18 (±34.22) | 0.695 |
| Skindex-16 emotions | 59.20 (±33.98) | 14.06 (±26.03) | <0.001 | 56.83 (±36.18) | 52.07 (±35.45) | 0.507 |
| Skindex-16 functioning | 44.27 (±36.16) | 13.67 (±29.93) | 0.011 | 43.14 (±37.52) | 38.76 (±35.60) | 0.550 |